Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
1996 Jul 09;9314:6907-12. doi: 10.1073/pnas.93.14.6907.
Show Gene links
Show Anatomy links
Mutational analysis and molecular modeling of the nonapeptide hormone binding domains of the [Arg8]vasotocin receptor.
Hausmann H
,
Richters A
,
Kreienkamp HJ
,
Meyerhof W
,
Mattes H
,
Lederis K
,
Zwiers H
,
Richter D
.
???displayArticle.abstract???
To identify determinants that form nonapeptide hormone binding domains of the white sucker Catostomus commersoni [Arg8]vasotocin receptor, chimeric constructs encoding parts of the vasotocin receptor and parts of the isotocin receptor have been analyzed by [(3,5-3H)Tyr2, Arg8]vasotocin binding to membranes of human embryonic kidney cells previously transfected with the different cDNA constructs and by functional expression studies in Xenopus laevis oocytes injected with mutant cRNAs. The results indicate that the N terminus and a region spanning the second extracellular loop and its flanking transmembrane segments, which contains a number of amino acid residues that are conserved throughout the nonapeptide receptor family, contribute to the affinity of the receptor for its ligand. Nonapeptide selectivity, however, is mainly defined by transmembrane region VI and the third extracellular loop. These results are complemented by a molecular model of the vasotocin receptor obtained by aligning its sequence with those of other G-protein coupled receptors as well as that of bacteriorhodopsin. The model indicates that amino acid residues of transmembrane regions II-VII that are located close to the extracellular surface also contribute to the binding of vasotocin.
Acher,
Molecular evolution of biologically active polypeptides.
1980, Pubmed
Acher,
Molecular evolution of biologically active polypeptides.
1980,
Pubmed
Baldwin,
Structure and function of receptors coupled to G proteins.
1994,
Pubmed
Birnbaumer,
Molecular cloning of the receptor for human antidiuretic hormone.
1992,
Pubmed
Chini,
Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor.
1995,
Pubmed
Coughlin,
Expanding horizons for receptors coupled to G proteins: diversity and disease.
1994,
Pubmed
Fong,
Localization of agonist and antagonist binding domains of the human neurokinin-1 receptor.
1992,
Pubmed
,
Xenbase
Gether,
Different binding epitopes on the NK1 receptor for substance P and non-peptide antagonist.
1993,
Pubmed
Gorbulev,
Molecular cloning and functional characterization of V2 [8-lysine] vasopressin and oxytocin receptors from a pig kidney cell line.
1993,
Pubmed
Hausmann,
Teleost isotocin receptor: structure, functional expression, mRNA distribution and phylogeny.
1995,
Pubmed
,
Xenbase
Higuchi,
A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions.
1988,
Pubmed
Hruby,
Conformational and structural considerations in oxytocin-receptor binding and biological activity.
1990,
Pubmed
Kaupmann,
Two amino acids, located in transmembrane domains VI and VII, determine the selectivity of the peptide agonist SMS 201-995 for the SSTR2 somatostatin receptor.
1995,
Pubmed
Kimura,
Structure and expression of a human oxytocin receptor.
1992,
Pubmed
,
Xenbase
Kojro,
Direct identification of an extracellular agonist binding site in the renal V2 vasopressin receptor.
1993,
Pubmed
Lolait,
Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus.
1992,
Pubmed
Mahlmann,
Structure, function, and phylogeny of [Arg8]vasotocin receptors from teleost fish and toad.
1994,
Pubmed
,
Xenbase
Manning,
Design, synthesis and some uses of receptor-specific agonists and antagonists of vasopressin and oxytocin.
1993,
Pubmed
Morel,
Molecular cloning and expression of a rat V1a arginine vasopressin receptor.
1992,
Pubmed
,
Xenbase
Mouillac,
The binding site of neuropeptide vasopressin V1a receptor. Evidence for a major localization within transmembrane regions.
1995,
Pubmed
Probst,
Sequence alignment of the G-protein coupled receptor superfamily.
1992,
Pubmed
Regoli,
Receptors for substance P and related neurokinins.
1989,
Pubmed
Schöneberg,
Plasma membrane localization and functional rescue of truncated forms of a G protein-coupled receptor.
1995,
Pubmed
Sharif,
Peptide receptors. Stepping up the pressure.
1992,
Pubmed
Skach,
Biogenesis and transmembrane topology of the CHIP28 water channel at the endoplasmic reticulum.
1994,
Pubmed
,
Xenbase
Sugimoto,
Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor.
1994,
Pubmed
,
Xenbase
Teeter,
Homology modeling of the dopamine D2 receptor and its testing by docking of agonists and tricyclic antagonists.
1994,
Pubmed
Thibonnier,
Molecular cloning, sequencing, and functional expression of a cDNA encoding the human V1a vasopressin receptor.
1994,
Pubmed
Ufer,
An extracellular residue determines the agonist specificity of V2 vasopressin receptors.
1995,
Pubmed